Search research articles
Contact Us
Filters
Showing results (511-520 of 605) with videos related to
Page
of 61
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> Carriers
Giulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Journal of General Internal Medicine
|
June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study
Lydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 Variants
Giulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
The New England Journal of Medicine
|
January 18, 1996
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
M G FitzGerald, D J MacDonald, M Krainer, et al.
The New England Journal of Medicine
|
June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal women
Paul E Goss, James N Ingle, José E Alés-Martínez, et al.
Breast Cancer Research : BCR
|
November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
Nadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment
|
February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Susan M Domchek, Tara M Friebel, Judy E Garber, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
Amin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Developmental Cell
|
May 26, 2022
A human breast atlas integrating single-cell proteomics and transcriptomics
G Kenneth Gray, Carman Man-Chung Li, Jennifer M Rosenbluth, et al.
Page
of 61
Search research articles
Search
Showing results (511-520 of 605) with videos related to
Sort By:
Page
of 61
Medrxiv : the Preprint Server for Health Sciences
|
November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> Carriers
Giulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Journal of General Internal Medicine
|
June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study
Lydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 Variants
Giulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
The New England Journal of Medicine
|
January 18, 1996
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
M G FitzGerald, D J MacDonald, M Krainer, et al.
The New England Journal of Medicine
|
June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal women
Paul E Goss, James N Ingle, José E Alés-Martínez, et al.
Breast Cancer Research : BCR
|
November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
Nadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment
|
February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Susan M Domchek, Tara M Friebel, Judy E Garber, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
Amin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Developmental Cell
|
May 26, 2022
A human breast atlas integrating single-cell proteomics and transcriptomics
G Kenneth Gray, Carman Man-Chung Li, Jennifer M Rosenbluth, et al.
Page
of 61